FranΓ§aisπ See the interactive version (live chart) β
For Corteva, we replayed every analyst price target of the past 12 months and measured the real outcome: 41% were profitable, average return +13% (168 calls). At 3 months: +2% average return (40% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Keybanc | 24 | 54% | +18% |
| Mizuho | 15 | 27% | +5% |
| RBC Capital | 14 | 57% | +16% |
| Wells Fargo | 14 | 36% | +10% |
| Citigroup | 13 | 31% | +10% |
Is Corteva overvalued, and is it a good time to buy Corteva right now? If you're wondering, here's a recap to make up your own mind: Corteva's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Corteva | Sector median (Materials) |
|---|---|---|
| P/E | 7.1 | 20.6 |
| Forward P/E | 10.2 | 14.3 |
| Net margin | 3% | 8% |
π Corteva trades below its sector median (7.1 vs 20.6) β potentially undervalued, or lower expected growth.
π P/E, PEG, marginβ¦: see the glossary
π΅ Dividend : Corteva pays about $0.72/share/yr β 0.86% yield. what is this?
The analyst consensus on Corteva (CTVA) is "Buy" (25 bullish, 0 bearish calls over 12 months). This is not advice: historically, 41% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $14.33 (+25% vs $11.47), ranging from $13.65 to $19.00 (12 analysts).
Over 1 year, 41% of analyst targets on Corteva were profitable, for an average return of +13% (across 168 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $14.33 within 12 months, i.e. +25% vs the current price. The most bullish targets $19.00, the most cautious $13.65.
Note: analyst targets are 12-month (median $14.33, +25%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (41%), and the stock's past trajectory.
Its P/E is 7.1, forward P/E 10.2. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of Corteva β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.